NCT00006325 - Safety, Tolerability, and Anti-HIV Activity of PEG-Intron in HIV-Positive Children | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

Not specified

Study Completion Date

March 31, 2004

Conditions

HIV Infections

Interventions

DRUG

Peginterferon alfa-2b

Trial Locations (15)

10037

Harlem Hosp Ctr, New York

11040

Schneider Children's Hosp, New Hyde Park

13210

SUNY Health Sciences Ctr at Syracuse / Pediatrics, Syracuse

32209

Univ of Florida Health Science Ctr / Pediatrics, Jacksonville

33161

Univ of Miami (Pediatric), Miami

77030

Texas Children's Hosp / Baylor Univ, Houston

90033

Los Angeles County - USC Med Ctr, Los Angeles

90801

Long Beach Memorial (Pediatric), Long Beach

900276016

Children's Hosp of Los Angeles/UCLA Med Ctr, Los Angeles

941430105

UCSF / Moffitt Hosp - Pediatric, San Francisco

060303805

Connecticut Children's Med Ctr, Farmington

021155724

Children's Hosp of Boston, Boston

01199

Baystate Med Ctr of Springfield, Springfield

016550001

Univ of Massachusetts Med School, Worcester

071032714

Univ of Medicine & Dentistry of New Jersey / Univ Hosp, Newark

All Listed Sponsors

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH